ritanserin has been researched along with ketamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
France, CP; Javors, MA; Koek, W; Li, JX; Rice, KC; Unzeitig, A | 1 |
Chaki, S; Fukumoto, K; Iijima, M | 1 |
Amato, D; Carey, RJ; de Souza Silva, MA; Groos, D; Huston, JP; Lauber, AC; Müller, CP; Pum, ME | 1 |
3 other study(ies) available for ritanserin and ketamine
Article | Year |
---|---|
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Animals; Conditioning, Operant; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Ketamine; Ketanserin; Male; Morphine; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the
Topics: Amino Acids; Animals; Antidepressive Agents; Dioxoles; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Feeding Behavior; Fenclonine; Ketamine; Male; Mice, Inbred C57BL; Neuropsychological Tests; Piperazines; Piperidines; Pyridines; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Ritanserin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Tryptophan Hydroxylase; Xanthenes | 2014 |
Neuropharmacology of light-induced locomotor activation.
Topics: Animals; Dopamine Agents; Dose-Response Relationship, Drug; Excitatory Amino Acid Agents; Haloperidol; Indoles; Ketamine; Light; Male; Motor Activity; Naphthyridines; Phencyclidine; Photic Stimulation; Piperazines; Piperidines; Pyridines; Quinpirole; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Ritanserin; Serotonin Antagonists | 2015 |